Literature DB >> 19858695

Diagnosis and treatment of malignant pleural effusion: a systematic literature review and new approaches.

Giuseppe Lombardi1, Fable Zustovich, Maria Ornella Nicoletto, Martin Donach, Grazia Artioli, Davide Pastorelli.   

Abstract

Malignant pleural effusion is a frequent complication in many types of tumors, and its presence indicates short expected survival. This review updates the current knowledge about diagnosis and management of malignant pleural effusion. In recent years, progress has been made in diagnosis through the use of new pathologic and radiologic approaches, such as the introduction of positron emission tomography-computed tomography, immunohistochemical marker combinations, and genetic studies to identify malignant cells. Treatment is always palliative. New promising drugs have been tested, but, awaiting randomized studies, talc pleurodesis is still the treatment of choice, although doubts remain about its safety. A long-term indwelling pleural catheter could be a valid alternative to talc pleurodesis in selected patients with trapped lung syndrome (a lung that fails to reexpand after drainage of pleural effusion) and short life expectancy. However, the correct treatment depends on several factors such as performance status, expected survival, presence of lung reexpansion following pleural drainage and comorbidities.

Entities:  

Mesh:

Year:  2010        PMID: 19858695     DOI: 10.1097/COC.0b013e3181aacbbf

Source DB:  PubMed          Journal:  Am J Clin Oncol        ISSN: 0277-3732            Impact factor:   2.339


  27 in total

1.  Hepatic breast cancer dissemination after an iatrogenic hepatic laceration during talc pleurodesis: a case report.

Authors:  Joaquim Bosch-Barrera; Jaime Espinós
Journal:  Int Arch Med       Date:  2010-05-06

2.  Tube thoracostomy: a review for the interventional radiologist.

Authors:  Jeremy R Hogg; Michael Caccavale; Benjamin Gillen; Gavin McKenzie; Jay Vlaminck; Chad J Fleming; Andrew Stockland; Jeremy L Friese
Journal:  Semin Intervent Radiol       Date:  2011-03       Impact factor: 1.513

3.  The palliative treatment with intrapleural streptokinase in patients with multiloculated malignant pleural effusion: a double-blind, placebo-controlled, randomized study.

Authors:  Ozkan Saydam; Kemal Karapinar; Mertol Gokce; Lutfiye Kilic; Muzaffer Metin; Ibrahim Ilker Oz; Ozgur Tanriverdi
Journal:  Med Oncol       Date:  2015-05-10       Impact factor: 3.064

Review 4.  A Primer on the Management of Pleural Effusions.

Authors:  William Bremer; Charles E Ray
Journal:  Semin Intervent Radiol       Date:  2019-02-05       Impact factor: 1.513

5.  A potential role for VEGF in the diagnostic approach of pleural effusions.

Authors:  Aggeliki Psatha; Demosthenes Makris; Theodora Kerenidi; Zoe Daniil; Theodoros Kiropoulos; Konstantinos Gourgoulianis
Journal:  J Thorac Dis       Date:  2016-07       Impact factor: 2.895

6.  Open window thoracostomy as an alternative approach to secondarily infected malignant pleural effusion and failure of intrapleural catheter drainage: a case report.

Authors:  Anthony M Villano; Raul Caso; M Blair Marshall
Journal:  AME Case Rep       Date:  2018-04-13

7.  Prolonged pleural catheters in the management of pleural effusions due to breast cancer.

Authors:  Ozkan Demirhan; Cetin Ordu; Alper Toker
Journal:  J Thorac Dis       Date:  2014-02       Impact factor: 2.895

8.  Diagnostic accuracy of vascular endothelial growth factor for malignant pleural effusion: A meta-analysis.

Authors:  Yong-Chun Shen; Meng-Qi Liu; Chun Wan; Lei Chen; Tao Wang; Fu-Qiang Wen
Journal:  Exp Ther Med       Date:  2012-03-14       Impact factor: 2.447

9.  Use of circulating tumor cell technology (CELLSEARCH) for the diagnosis of malignant pleural effusions.

Authors:  Daniel E Schwed Lustgarten; Jeffrey Thompson; Gordon Yu; Anil Vachani; Bhavesh Vaidya; Chandra Rao; Mark Connelly; Michelle Udine; Kay See Tan; Daniel F Heitjan; Steven Albelda
Journal:  Ann Am Thorac Soc       Date:  2013-12

10.  Determination of 35 cell surface antigen levels in malignant pleural effusions identifies CD24 as a marker of disseminated tumor cells.

Authors:  Xiaosai Yao; Myriam Labelle; Carla R Lamb; John M Dugan; Christina A Williamson; Donna R Spencer; Kimberly R Christ; Ryan O Keating; W David Lee; Glenn A Paradis; Shahinoor Begum; Richard O Hynes; K Dane Wittrup
Journal:  Int J Cancer       Date:  2013-07-13       Impact factor: 7.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.